Navigation Links
Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
Date:5/23/2012

BALTIMORE, May 23, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in Pain Medication Monitoring Solutions®, will launch new resources aimed at helping physicians manage compliance and ethics issues when working with laboratory partners. Health professionals will have access to a new website offering important regulatory compliance information.

"Our goal as a company is to provide the resources, support and services that help physicians focus on what they do best – achieve better outcomes for their patients. For that reason, we offer a compliance program that adheres to all laws and regulations for laboratories, and contributes to strong patient care and trust among physicians and payors," said Regina Morano, J.D., CHC, Corporate Compliance Officer & Vice President. "Beyond the technical monitoring and information services offered, these 24/7 web resources enable health professionals to see our strong commitment to compliance and ethics and to focus on patient care."

Ameritox works closely with independent and Federal agencies to review its customer support programs. Developed in strict adherence to Office of Inspector General (OIG) guidelines and recommendations, the Ameritox best-in-class compliance program seeks to provide physicians with an information platform that meets the highest standards for interactions with the pain medication monitoring industry.

"Integrity is one of the pillars of our company's values, and we make that value inherent in every decision we undertake and every process we establish at Ameritox," said Ancelmo Lopes, Chief Executive Officer. "We're proud to offer this new package of tools to physicians, so that they can be assured that they are meeting the highest compliance standards – and can then focus on the needs of their patients."

Ameritox is a corporate member of the Health Care Compliance Association, and commends HCCA for its success in increasing awareness of the importance of compliance and ethics in the health care industry.

Ameritox's Compliance Program was designed to ensure that the organization adheres to all legal, ethical and regulatory laws, policies and standards in its industry. As the national leader in pain medication monitoring, Ameritox developed its program under the highest standards that OIG established in the publication "Compliance Program Guidelines for Clinical Laboratories." OIG standards are available in the Federal Register: http://oig.hhs.gov/authorities/docs/cpglab.pdf

About Ameritox

Ameritox is the nation's leader in Pain Medication Monitoring Solutions®, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers the most thorough pain medication monitoring lab process – Rx Guardian(SM) – with Rx Guardian CD(SM), the only pain medication monitoring process with a proprietary normalization algorithm and a reference database of pain patients clinically assessed for medication adherence. Patient results are compared against this database, helping physicians assess whether patients are taking their pain medications correctly. Monitoring through urine drug testing helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas and Greensboro, N.C. Ameritox can be found online at www.ameritox.com, on Twitter @Ameritox, on Facebook at facebook.com/ameritox on YouTube at youtube.com/ameritox or on LinkedIn through Ameritox's company page.

© 2012 Ameritox Ltd. All rights reserved. AMERITOX, the AMERITOX logos, AMERITOX AUTOREMINDER, AMERITOX MEDICATION MONITORING SOLUTIONS, AMERITOX UNIVERSITY, PAIN MEDICATION MONITORING SOLUTIONS, POWERED BY YOUR NEED TO KNOW and PROTECT YOUR PATIENTS. PROTECT YOUR PRACTICE. RX GUARDIAN, RX GUARDIAN CD, and RX GUARDIAN AUTOREMINDER are trademarks of Ameritox.

Contact:
Lon Wagner
336-387-7742
lon.wagner@ameritox.com


'/>"/>
SOURCE Ameritox
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
2. Ameritox Commends Operation UNITE on Its Inaugural National Rx Drug Abuse Summit
3. Ameritox Supports New Expert Consensus Recommendations For Patients on Long-Term Opioid Therapy
4. Ameritox Provides Educational Support to Clinicians to Help Reduce Opioid Misuse, Abuse and Diversion
5. Ameritox Supports Federal Implementation of Medication Monitoring for Chronic Pain Patients
6. Ameritox® Continues to Advance Industry Leadership
7. Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
8. MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent
9. PolyOne Announces Expansion in Costa Rica with Healthcare-Focused Distribution Services
10. ThermoGenesis Announces Axp Approval In Thailand
11. Comprehensive Care Corporation Announces Profit for First Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... offer newly issued shares of common stock, $0.01 par value ... an underwritten public offering.  The final terms of the Offering ... of pricing, and there can be no assurance as to ... IRIDEX expects to use the net proceeds it will receive ...
(Date:12/8/2016)... -- Global Interventional Radiology Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
(Date:12/8/2016)... 2016  Eli Lilly and Company (NYSE: ... 3 EXPEDITION3 trial at the 9 th Clinical ... solanezumab did not meet the primary endpoint in the ... people with mild dementia due to Alzheimer,s disease (AD), ... for the treatment of mild dementia due to AD. ...
Breaking Medicine Technology:
(Date:12/8/2016)... San Francisco, California (PRWEB) , ... December 08, 2016 , ... ... health coaches, has raised an $18M Series B led by Canvas Ventures . ... use the capital to scale its mobile platform to serve more consumers who are ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dan Carlisle Agency, ... Jefferson County, is announcing the launch of a charity drive to raise support ... homeless women and children in Birmingham has grown steadily since the 1980’s, and ...
(Date:12/8/2016)... , ... December 08, 2016 , ... The Compretta Insurance ... and residential clients in and around the Hancock County area, is announcing the launch ... County Food Pantry. , The Hancock County Food Pantry has worked for more than ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... DrugDev ... the announcement that it is one of the early adopters completing EU-U.S. Privacy Shield ... is designed to provide companies on both sides of the Atlantic with a mechanism ...
(Date:12/7/2016)... Kenosha, Wisconsin (PRWEB) , ... December 07, 2016 , ... ... the extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED ... the right amount of light where and when it’s needed. , A ...
Breaking Medicine News(10 mins):